MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
148 hedge funds and large institutions have $536M invested in Momenta Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
-10
Holders Change %
-6.33%
% of All Funds
4.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
51
Reduced
49
Closed
35
Calls
$7.94M
Puts
$10.3M
Net Calls
-$2.32M
Net Calls Change
-$4.17M
Top Buyers
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$30.2M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$10.7M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$6.81M |
| 4 |
Primecap Management
Pasadena,
California
|
+$6.18M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.05M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.98M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$6.84M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.17M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$4.66M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.46M |
